Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Roberta D'Ambrosio"'
Autor:
Christiana Graf, Roberta D’Ambrosio, Elisabetta Degasperi, Stefania Paolucci, Jordi Llaneras, Johannes Vermehren, Georg Dultz, Kai-Henrik Peiffer, Fabian Finkelmeier, Eva Herrmann, Stefan Zeuzem, Maria Buti, Pietro Lampertico, Julia Dietz, Christoph Sarrazin
Publikováno v:
JHEP Reports, Vol 6, Iss 3, Pp 100994- (2024)
Background & Aims: Voxilaprevir/velpatasvir/sofosbuvir (VOX/VEL/SOF) is highly effective for re-treatment of direct-acting antiviral (DAA)-experienced patients with chronic HCV infection. In the present study, predictors of virologic treatment respon
Externí odkaz:
https://doaj.org/article/19457f73f2454109b2631336ff2f0579
Autor:
Laura Micheli, Alessandra Pacini, Lorenzo Di Cesare Mannelli, Elena Trallori, Roberta D’Ambrosio, Carlo Bianchini, Pietro Lampertico, Carla Ghelardini
Publikováno v:
Nutrients, Vol 16, Iss 13, p 2130 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/a3769eb50377457ca45d60d7967164bf
Autor:
Maria Giovanna Quaranta, Luisa Cavalletto, Francesco Paolo Russo, Vincenza Calvaruso, Luigina Ferrigno, Alberto Zanetto, Benedetta Mattioli, Roberta D’Ambrosio, Valentina Panetta, Giuseppina Brancaccio, Giovanni Raimondo, Maurizia Rossana Brunetto, Anna Linda Zignego, Carmine Coppola, Andrea Iannone, Elisa Biliotti, Elena Rosselli Del Turco, Marco Massari, Anna Licata, Francesco Barbaro, Marcello Persico, Filomena Morisco, Maurizio Pompili, Federica Cerini, Massimo Puoti, Teresa Santantonio, Antonio Craxì, Loreta A. Kondili, Liliana Chemello, on behalf of PITER Collaborating Investigators
Publikováno v:
Viruses, Vol 16, Iss 5, p 682 (2024)
The treatment of hepatitis C virus (HCV) with direct-acting antivirals (DAA) leads to high sustained virological response (SVR) rates, but hepatocellular carcinoma (HCC) risk persists in people with advanced liver disease even after SVR. We weighted
Externí odkaz:
https://doaj.org/article/0a099c6b55904c89a7f8b467d025b283
Autor:
Luca Valenti, Serena Pelusi, Alessio Aghemo, Sara Gritti, Luisa Pasulo, Cristiana Bianco, Claudia Iegri, Giuliana Cologni, Elisabetta Degasperi, Roberta D’Ambrosio, Paolo delPoggio, Alessandro Soria, Massimo Puoti, Isabella Carderi, Marie Graciella Pigozzi, Canio Carriero, Angiola Spinetti, Valentina Zuccaro, Massimo Memoli, Alessia Giorgini, Mauro Viganò, Maria Grazia Rumi, Tiziana Re, Ombretta Spinelli, Maria Chiara Colombo, Tiziana Quirino, Barbara Menzaghi, Gianpaolo Lorini, Angelo Pan, Antonella D’Arminio Monforte, Elisabetta Buscarini, Aldo Autolitano, Paolo Bonfanti, Natalia Terreni, Gianpiero Aimo, Monia Mendeni, Daniele Prati, Pietro Lampertico, Massimo Colombo, Stefano Fagiuoli, for the NAVIGATORE‐Lombardia Network
Publikováno v:
Hepatology Communications, Vol 6, Iss 4, Pp 867-877 (2022)
The aim of this study was to examine the impact of features of dysmetabolism on liver disease severity, evolution, and clinical outcomes in a real‐life cohort of patients treated with direct acting antivirals for chronic hepatitis C virus (HCV) inf
Externí odkaz:
https://doaj.org/article/aa68b6c6c97b421f9c04627e6eb981ed
Autor:
Alessio Aghemo, Marcello Persico, Roberta D'Ambrosio, Massimo Andreoni, Erica Villa, Abhi Bhagat, Valentina Gallinaro, Giuliana Gualberti, Rocco Cosimo Damiano Merolla, Antonio Gasbarrini
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0280165 (2023)
IntroductionGlecaprevir/pibrentasvir (G/P) has demonstrated high rates (>95%) of sustained virologic response at posttreatment Week 12 (SVR12) in treatment-naïve (TN) patients with hepatitis C virus (HCV) infection and compensated cirrhosis (CC). He
Externí odkaz:
https://doaj.org/article/be07dcb5e1924a0cab48cd044e7a2346
Autor:
Luca Valenti, Armando Tripodi, Vincenzo La Mura, Serena Pelusi, Cristiana Bianco, Erica Scalambrino, Sara Margarita, Francesco Malvestiti, Luisa Ronzoni, Marigrazia Clerici, Roberta D’Ambrosio, Mirella Fraquelli, Rossana Carpani, Daniele Prati, Flora Peyvandi
Publikováno v:
JHEP Reports, Vol 4, Iss 12, Pp 100598- (2022)
Background & Aims: The aim of this study was to examine the determinants of the interplay between liver damage and the coagulation balance in individuals at risk of non-alcoholic fatty liver disease (NAFLD). Methods: We considered 581 healthy partici
Externí odkaz:
https://doaj.org/article/b046f8d74d0441cfa9d42ff22e969629
Autor:
Luca Valenti, Serena Pelusi, Cristiana Bianco, Ferruccio Ceriotti, Alessandra Berzuini, Laura Iogna Prat, Roberta Trotti, Francesco Malvestiti, Roberta D’Ambrosio, Pietro Lampertico, Agostino Colli, Massimo Colombo, Emmanuel A. Tsochatzis, Mirella Fraquelli, Daniele Prati
Publikováno v:
Hepatology Communications, Vol 5, Iss 11, Pp 1824-1832 (2021)
The changing epidemiology of liver disease, and modifications in the recommended analytical methodology call for a re‐evaluation of the upper reference limits (URLs) of alanine aminotransferase (ALT) levels. Using the same approach consolidated 20
Externí odkaz:
https://doaj.org/article/67bd080d277d42938c6f1bd9e6af2831
Autor:
Roberta D’Ambrosio, George N. Ioannou
Publikováno v:
Hepatology Communications, Vol 5, Iss 9, Pp 1465-1468 (2021)
Externí odkaz:
https://doaj.org/article/baed31704e824b7a9f941bbfac4e2bd5
Autor:
Alessandra Scagliola, Annarita Miluzio, Gabriele Ventura, Stefania Oliveto, Chiara Cordiglieri, Nicola Manfrini, Delia Cirino, Sara Ricciardi, Luca Valenti, Guido Baselli, Roberta D’Ambrosio, Marco Maggioni, Daniela Brina, Alberto Bresciani, Stefano Biffo
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-16 (2021)
Lipid accumulation in the liver leads to nonalcoholic fatty liver disease (NAFLD) that is a risk factor for developing hepatocellular carcinoma (HCC). Here, the authors show that activation of the translation initiation factor eIF6 promotes lipid acc
Externí odkaz:
https://doaj.org/article/c2901b240ab0477f819e12cbe5532a69
Autor:
Roberta D'Ambrosio, Irene Campi, Marco Maggioni, Riccardo Perbellini, Enza Giammona, Roberta Stucchi, Marta Borghi, Elisabetta Degasperi, Annalisa De Silvestri, Luca Persani, Laura Fugazzola, Pietro Lampertico
Publikováno v:
PLoS ONE, Vol 16, Iss 4, p e0249614 (2021)
BackgroundData on the role of hypothyroidism in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are conflicting, although selective Thyroid Hormone Receptor (THR)-β agonists have been identified as potential therapy
Externí odkaz:
https://doaj.org/article/d2e0fbea9990438f8cabd83bde15264b